🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Das Produkt enthält den Wirkstoff Bimatoprost, der Augen- und ophthalmologische Nebenwirkungen verursachen kann (z. B. Juckreiz und Schwellung der Augenlider, Augenlidentzündung, Hyperpigmentierung der Augenlider, Bindehautrötung, Augenschmerzen oder allergische Reaktionen).
Action taken by the authority
Type of economic operator to whom the measure were ordered
Distributor
Category of measure
Securing the inventory
Date of entry into force
12/12/2016
Type of economic operator taking notified measure
Distributor
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Eyelash Enhancing Serum
Risk Description (original English): The product contains the active substance bimatoprost, which could result in ocular and ophthalmic side effects (e.g. itching and swelling of the eyelids, eyelid inflammation, hyperpigmentation of the eyelids, conjunctival hyperaemia, eye pain or allergic reaction).
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.